_parp-inhibitors-and-their-evolving-role-for-the-treatment-of-prostate-cancer.jpg "PARP inhibitors and their evolving role for the treatment of prostate cancer from parp Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 23 min 26 sec
✓ Published: 24-Sep-2020
✓ Published: 24-Sep-2020
Description:
Drs Shore, Agarwal, Castro and Chi discuss the latest in PARP inhibitors in prostate cancer.nnStarting with some background on the science involved in PARP inhibition, they cover some of the major studies presented at ESMO 2020:nn- PROfoundn- TALAPRO-1n- KEYNOTE-365n- TRITON2n- NADIRnnThe panel discuss the science behind the studies and their potential impact on clinical practice from a global perspective.nnThey cover the increasing importance of testing, the differ
Drs Shore, Agarwal, Castro and Chi discuss the latest in PARP inhibitors in prostate cancer.nnStarting with some background on the science involved in PARP inhibition, they cover some of the major studies presented at ESMO 2020:nn- PROfoundn- TALAPRO-1n- KEYNOTE-365n- TRITON2n- NADIRnnThe panel discuss the science behind the studies and their potential impact on clinical practice from a global perspective.nnThey cover the increasing importance of testing, the differ
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_parp11.webp "PARP11 from parp")
_parp-inhibitor-olaparib-slows-progression-of-advanced-prostate-cancer.webp "Prof Maha Hussain presents data from thePROfound trial during a press conference at the 2019 ESMO congress.nnThis was a trial evaluating the PARP inhibitor olaparib vs new hormonal agents in patients with metastatic, pre-treated prostate cancer whose cancer cells had faulty DNA repair genes.nnSign up to ecancer for free to receive tailored email alerts for more videos like this.necancer.org/account/register.php")
_breast-cancer-treatment.webp "Animation showing a drug MOA for treating breast cancer.")
_parp-inhibitor-maintenance-therapy-for-pancreatic-cancer-with-brca-mutation.webp "At the 2019 Great Debates and Updates in GI Malignancies meeting, Eileen O'Reilly, MD, debated in favor of using PARP inhibitors as maintenance therapy for patients with BRCA mutation–positive pancreatic cancer.")
⏲ 1 min 51 sec ✓ 14-Sep-2019
_parp-inspiracje-odblaski-124-darek-zatorski.webp "PARP - Inspiracje - Odblaskindir: Darek Zatorskinnprezentacja dorobku - creative showcasenpoint of you")
_part-3-mechanism-of-action-of-parp-inhibitors.webp "Short chapter from the Mechanism of Action of PARP inhibitors and Targeting DNA Damage Response (DDR) video")
_comment-on-solo1-for-advanced-ovarian-cancer.webp "Dr Ledermann speaks with ecancer at ESMO 2018 in Munich about the SOLO1 study of 2 years maintenance olaparib following platinum-based chemotherapy for patients with newly diagnosed advanced ovarian cancer and a BRCA1/2 mutation.nnHe emphasises the improved PFS at 3 years with the PARP inhibitor (HR 0.3), with no change in health-related quality of life from standard care.nnThese results were first presented by Dr Kathleen Moore in a conference session.nnecancer's filming has been kindly support")
_too-tall-tina.webp "Cindy Clifford from WALK RADIO 97.5 reads an original story to a fourth grade class at the Riley Avenue School during Parents as Reading Partners Reading Week.")
_parp11.jpg)
_parp-inhibitor-olaparib-slows-progression-of-advanced-prostate-cancer.jpg)
_breast-cancer-treatment.jpg)
_parp-inhibitor-maintenance-therapy-for-pancreatic-cancer-with-brca-mutation.jpg)
_parp-inspiracje-odblaski-124-darek-zatorski.jpg)
_part-3-mechanism-of-action-of-parp-inhibitors.jpg)
_comment-on-solo1-for-advanced-ovarian-cancer.jpg)
_too-tall-tina.jpg)
![[+]](/images/menu.gif){kind=small}